Package 85509-1180-1

{"route": ["ORAL"], "spl_id": "3a7b7ba1-4796-0e38-e063-6294a90a44fc", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313413"], "spl_set_id": ["3a7b9b9a-9bf9-0b37-e063-6294a90a1c39"], "manufacturer_name": ["PHOENIX RX LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (85509-1180-1)", "package_ndc": "85509-1180-1", "marketing_start_date": "20250731"}, {"sample": false, "description": "28 TABLET in 1 BOTTLE (85509-1180-2)", "package_ndc": "85509-1180-2", "marketing_start_date": "20250731"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (85509-1180-3)", "package_ndc": "85509-1180-3", "marketing_start_date": "20250731"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (85509-1180-6)", "package_ndc": "85509-1180-6", "marketing_start_date": "20250731"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (85509-1180-9)", "package_ndc": "85509-1180-9", "marketing_start_date": "20250731"}], "brand_name": "Tizanidine", "product_id": "85509-1180_3a7b7ba1-4796-0e38-e063-6294a90a44fc", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "85509-1180", "generic_name": "Tizanidine", "labeler_name": "PHOENIX RX LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA076286", "marketing_category": "ANDA", "marketing_start_date": "20020703", "listing_expiration_date": "20261231"}